|
IN
THE NEWS
|
EDIT
|
Wockhardt
sets up subsidiary in Brazil, forms JVs in Mexico, South
Africa for biopharmaceuticals
Matrix
Labs in tie-up with MCHEM
IDMA urges
for uniform implementation of VAT by all states |
Editorial
The HIV Conundrum
Edit Article
Drug utilisation
studies: The need for a common protocol
|
|
OPED
|
HAPPENINGS
|
|
Documentation:
A reliable evidence for GMP compliance
The system of documentation devised or adopted should
have as its main objective to establish, monitor, and
record “quality” for all aspects of the production,
quality control and quality assurance, says J Ramnivas
|
Pharma
majors eye Chilean patients
Novo-Nordisk,
LifeScan launch Diabetes Starter Pack in India
Public-private
partnership crucial for biotech growth: Dr Bhan
|
|
HEALTH
NEWS
|
TECHNOLOGY
TRENDZ
|
|
Apex
Body for accreditating hospitals & healthcare providers
on the anvil
Complaint
filed against doctor, publisher for sex determination
article
Taj
plans tie-up with healthcare institutions
|
Brand
protection and anti-counterfeiting measures
Whatever their effect on safety and security, unit-of-use
bar code labelling, anti-counterfeiting and RFID marking
initiatives will have a huge impact on pharmaceutical
labelling, says Shailesh Deshmukh
|
|
BOOK REVIEW
|
MARKETPLACE
|
|
Unravelling
pharmaceutical microbiology
The book Pharmaceutical Microbiology is the second edition
authored by N K Jain. It has been revised and updated
keeping in view the reviews and the feedback received
from the readers without overloading the subject matter.
|
A little
of that human touch
Seminars, conferences and other events have to prove
themselves as good marketing tools where the use of
measurement criteria to ascertain the return on investment
is crucial, finds Chetna Rathod
|
|
PRODUCT
|
CONVERSATION
|
|
Product
|
‘‘Good
potential for Indo-US co-operation in drug discovery’’
Maryland’s deputy secretary of Business and Economic
Development Christopher C Foster is responsible for
the day-to-day operations of the state’s commerce
department. In an exclusive interview with R BabyManoj,
he dwelt on the potential of Maryland as an investment
destination for Indian bio-pharmapreneurs in general
and the potential of Indo-US co-operation in the field
of drug discovery and development. Excerpts:
|
